Chlamydia trachomatis ine Research through the Years.pdf.pdf

Hindawi Publishing CorporationInfectious Diseases in Obstetrics and GynecologyVolume 2011, Article ID963513,9pagesdoi: ine Research through the YearsKatelijn Schautteet, Evelien De Clercq, and Daisy VanrompayDepartment of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, 9000 Ghent, BelgiumCorrespondence should be addressed to Katelijn Schautteet,katelijn.******@ 17 January 2011; Revised 13 April 2011; Accepted 2 May 2011Academic Editor: J. PaavonenCopyright ? 2011 Katelijn Schautteet et al. This is an open access article distributed under the mons AttributionLicense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is trachomatisis a Gram-negative obligate intracellular bacterium. It is the leading cause of bacterial sexual transmittedinfections (STIs). World anization ?gures estimated that over 90 million new cases of genitalC. ur worldwide each year. A ination programis considered to be the best approach to reduce the prevalence ofC. trachomatisinfections, as it would be much cheaper and have a greater impact on controllingC. trachomatisinfections worldwide rather thana screening program or treating infections with antibiotics. Currently, there are no ines available which e?ectively protectagainst aC. trac